Status
Conditions
Treatments
About
This randomised study will assess whether Parafricta bootees, when used in addition to normal standard care, can reduce the incidence of heel PUs in patients at very high risk of skin breakdown. The participant group will be hospital inpatients at high risk of PUs (Waterlow score of 20 or more) who are bedbound and do not have existing heel PUs. The participants will be randomised to an intervention arm using Parafricta plus standard care, or a control arm of standard care only. The primary outcome is incidence of heel PUs at day 3. Secondary outcomes are incidence of PUs at day 14, length of stay, severity of PUs, patient acceptability of device, cost-effectiveness.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The eligibility criteria for this study at the time of recruitment were:
Exclusion criteria
• Patients with a single or double lower limb amputation were not eligible to participate in the study.
Primary purpose
Allocation
Interventional model
Masking
31 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal